Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 6,838 | 15,688 | 13,988 | 17,024 | 18,910 |
| Operating Income | -6,838 | -15,688 | -13,988 | -17,024 | -18,910 |
| Interest Expense | -188 | 2,449 | 361 | 357 | 418 |
| Other Income | -1 | -526 | 4 | -159 | -375 |
| Pre-tax Income | -6,652 | -18,663 | -14,344 | -17,540 | -19,703 |
| Income Tax | 3 | N/A | 1 | N/A | 2 |
| Net Income Continuous | -6,654 | -18,663 | -14,345 | -17,540 | -19,705 |
| Net Income | $-6,654 | $-18,663 | $-14,345 | $-17,540 | $-19,705 |
| EPS Basic Total Ops | -0.52 | -1.60 | -1.20 | -1.60 | -1.80 |
| EPS Basic Continuous Ops | -0.52 | -1.64 | -1.30 | -1.59 | -1.80 |
| EPS Diluted Total Ops | -0.52 | -1.60 | -1.20 | -1.60 | -1.80 |
| EPS Diluted Continuous Ops | -0.52 | -1.64 | -1.30 | -1.59 | -1.80 |
| EBITDA(a) | $-6,827 | $-15,677 | $-13,936 | $-16,973 | $-18,859 |